Novel pharmacotherapies for obesity poised to enter market.
Jones
Dan
D
D000328:Adult; D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001066:Appetite / Q000187:drug effects*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000453:epidemiology; D012528:Satiety Response / Q000187:drug effects; D014481:United States / Q000453:epidemiology
D019440:Anti-Obesity Agents